Craft

Bachem Holding

Stock Price

CHF70

2024-10-29

Market Capitalization

CHF5.2 B

2024-10-29

Revenue

CHF695.1 M

FY, 2025

Bachem Holding Summary

Company Summary

Overview
Bachem Holding is a company that manufactures ingredients for pharmaceuticals, generic drugs, and research supplies. It produces peptides and amino acids for medications and laboratory research, and prescription medicines that are no longer patent protected. Bachem Holding sells its products to universities, and pharmaceutical and biotechnology companies.
Type
Public
Status
Active
Founded
1971
HQ
Bubendorf, CH | view all locations
Website
http://www.bachem.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Peter Grogg

    Peter Grogg, Honorary Chairman

    • Kuno Sommer

      Kuno Sommer, Chairman

      • Thomas Meier

        Thomas Meier, CEO

        • Roland Schürmann

          Roland Schürmann, COO

          LocationsView all

          3 locations detected

          • Bubendorf, BL HQ

            Switzerland

            Hauptstrasse 144

          • Torrance, CA

            United States

            3132 Kashiwa St

          • Tokyo, Tokyo

            Japan

            Nihonbashi Life Science Building 7, 8F 1-9-10 Nihonbashi-Horidome cho

          Bachem Holding Financials

          Summary Financials

          Revenue (FY, 2025)
          CHF695.1M
          Gross profit (FY, 2025)
          CHF264.2M
          Net income (FY, 2025)
          CHF148.8M
          Cash (FY, 2025)
          CHF31.0M
          EBIT (FY, 2025)
          CHF167.3M
          Enterprise value
          $5.3B

          Footer menu